Case Studies

Dr. Palanki Satya Dattatreya

Role Of Tumor DNA Profiling For EGFR Mutation Status At Baseline In Lung Cancer When Liquid Biopsy Fails!!

This is a case which is unique in terms of how liquid biopsy could fail sometimes and tissue remains the gold standard for EGFR mutation status assessment.

April 15, 2022

Dr. Sandeep Jasuja

Role of CGP to identify new options beyond the standard of care in recurrent cancers in progression

The case study on Leiomyosarcoma reveals CGP's ability to discover potential treatment options for progressive cancers that are recurrent.

April 15, 2022

Dr. Hemanth Kumar

Role of CGP in overcoming the roadblocks in Cancer treatment

The case study emphasizes the importance of CGP based on the biomarkers identified in the tumor in turn personalizing the cancer treatment to the patient.

January 18, 2023

Dr. C N Patil

Role of CGP during relapse or disease progression in GIST

This is a case which demonstrates the beneﬁts of Comprehensive genome proﬁling by NGS in identifying biomarkers for therapy resistance in GIST. Providing therapies to GIST patients with KIT mutations once they have progressed on ﬁrst and second lines of treatment and understanding the underlying mechanisms of resistance.

April 15, 2022

Dr. Aparna Sreevatsa

Rare oncogenic fusion CD74-NRG1 detection in lung cancer patient

This case demonstrates the value of CGP in NSCLC patients who do not harbour any well-known driver mutations in genes such as EGFR, KRAS, ALK, ROS1, RET, MET, and NTRK, instead harbour other targetable alterations that would potentially benefit the patient.

July 8, 2022

Prof. Dr. MD. Mofazzel Hossain

Novel ESR1 gene fusion detected through the CGP as a probable mechanism of resistance to endocrine therapy

This is a case where Genetic testing was chosen by the consulting physician to determine potential therapeutic alternatives and the underlying cause of endocrine therapy resistance.

April 15, 2022

Dr. Kripa Bajaj

Exploring BRCA beyond what we know

This case demonstrates the importance of genetic testing in individuals presenting with non-classical syndrome like history.

January 5, 2023

Clinical Case Studies

Dr. Palanki Satya Dattatreya

Role Of Tumor DNA Profiling For EGFR Mutation Status At Baseline In Lung Cancer When Liquid Biopsy Fails!!

This is a case which is unique in terms of how liquid biopsy could fail sometimes and tissue remains the gold standard for EGFR mutation status assessment.

Dr. Sandeep Jasuja

Role of CGP to identify new options beyond the standard of care in recurrent cancers in progression

The case study on Leiomyosarcoma reveals CGP's ability to discover potential treatment options for progressive cancers that are recurrent.

Dr. Hemanth Kumar

Role of CGP in overcoming the roadblocks in Cancer treatment

The case study emphasizes the importance of CGP based on the biomarkers identified in the tumor in turn personalizing the cancer treatment to the patient.

Dr. C N Patil

Role of CGP during relapse or disease progression in GIST

Dr. Aparna Sreevatsa

Rare oncogenic fusion CD74-NRG1 detection in lung cancer patient

This case demonstrates the value of CGP in NSCLC patients who do not harbour any well-known driver mutations in genes such as EGFR, KRAS, ALK, ROS1, RET, MET, and NTRK, instead harbour other targetable alterations that would potentially benefit the patient.

Prof. Dr. MD. Mofazzel Hossain

Novel ESR1 gene fusion detected through the CGP as a probable mechanism of resistance to endocrine therapy

This is a case where Genetic testing was chosen by the consulting physician to determine potential therapeutic alternatives and the underlying cause of endocrine therapy resistance.

Dr. Kripa Bajaj

Exploring BRCA beyond what we know

This case demonstrates the importance of genetic testing in individuals presenting with non-classical syndrome like history.